Automating Brain Organoids to Boost Neurodegenerative Research

Brain organoids are transforming how researchers model complex neurological diseases, but growing them manually is slow, inconsistent and hard to scale. Automation is helping solve these challenges, enabling more reproducible cultures and better long-term viability—critical for conditions like Alzheimer's disease and Parkinson's disease, which require long-term study.

What Makes Modeling Neurodegenerative Conditions Particularly Challenging?

Neurodegenerative diseases are defined by progressive cellular and network-level changes that unfold over months or years. Replicating this timeline in vitro requires culture systems that remain stable, healthy, and well-characterized over equivalent durations. Brain organoids can self-organize into three-dimensional neural structures that recapitulate aspects of human brain development and disease pathology—including plaque formation similar to what is seen in patients.

The Case for Automation

There are three key advantages of using automated systems for brain organoid cultivation. First, they achieve the reproducibility required for consistency at scale. Second, they have the monitoring capabilities by light microscopy essential for quality control. Third, they provide the scalability needed for meaningful research.

Manually maintaining just 10 brain organoid plates requires nearly 30 hours of hands-on time each week, but automation reduces this to just a few hours. Brain organoids need to be cultured for—on average—100 days, with 60 plates in a system requiring daily feeding and imaging. This is more work than a single person can manage, in addition to a huge amount of data that is nearly impossible to acquire manually.

Rocking Incubator Technology

The new rocking incubator in the CellXpress.ai® Automated Cell Culture System is crucial for automating the successful generation of brain organoids because it allows them to be kept in motion. This improved nutrient delivery and waste removal significantly extends viability and quality throughout the culture period.

AI-Driven Analysis at Scale

The integration of AI-driven image analysis tools within the CellXpress.ai® platform enables automated quality assessment of organoid morphology, growth kinetics, and structural organization—transforming large imaging datasets into actionable biological insight. This addresses one of the major bottlenecks in scaling neurodegenerative disease research: handling, organizing, and analyzing vast amounts of imaging data generated over long culture periods.